Profusa (PFSA) Accounts Payables (2024 - 2026)

Profusa (PFSA) posted quarterly Accounts Payables of $8.3 million for Q1 2026, up 13.12% quarter-over-quarter from $7.3 million in Q4 2025.

Profusa (PFSA) Accounts Payables (2024 - 2026) Analysis & Trends

Profusa's Accounts Payables history runs 3 years deep, the most recent figure standing at $8.3 million for Q1 2026.

In Q1 2026, Accounts Payables changed N/A year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (changed N/A YoY), while the FY2025 annual figure was $7.3 million, up 48.26% from the prior year.
Accounts Payables for Q1 2026 stood at $8.3 million, up from $7.3 million in the prior quarter.
The five-year high for Accounts Payables was $8.3 million in Q1 2026, with the low at -$49000.0 in Q3 2025.
The 3-year median for Accounts Payables is $6.1 million (2024), against an average of $5.1 million.
Peak annual rise in Accounts Payables reached 48.26% in 2025, while the deepest fall reached 48.26% in 2025.
Profusa's Accounts Payables stood at $5.0 million in 2024, then surged by 48.26% to $7.3 million in 2025, then increased by 13.12% to $8.3 million in 2026.
Business Quant data shows PFSA's Accounts Payables at $8.3 million in Q1 2026, $7.3 million in Q4 2025, and -$49000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Abbott Laboratories	202.88 Bn	197.28 Bn	7.27 Bn	4.79 Bn
2	Stryker	126.34 Bn	122.87 Bn	4.50 Bn	1.66 Bn
3	Medtronic	119.78 Bn	110.56 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	74.35 Bn	73.81 Bn	3.85 Bn	1.23 Bn
5	Edwards Lifesciences	51.73 Bn	47.47 Bn	1.35 Bn	210.50 Mn
6	Dexcom	35.36 Bn	33.41 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.85 Bn	31.74 Bn	2.18 Bn	3.23 Bn
8	Koninklijke Philips	26.23 Bn	22.91 Bn	4.55 Bn	2.42 Bn
9	Steris	23.23 Bn	22.75 Bn	684.20 Mn	344.10 Mn
10	Profusa	94,449.19	-280,550.81	-	8.31 Mn

Download Data